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Abstract
Persistence of HIV DNA presents a major barrier to the complete control of HIV infection under current therapies. Most
studies suggest that cells with latently integrated HIV decay very slowly under therapy. However, it is much more difficult to
study the turnover and persistence of HIV DNA during active infection. We have developed an ‘‘escape clock’’ approach for
measuring the turnover of HIV DNA in resting CD4+ T cells. This approach studies the replacement of wild-type (WT) SIV
DNA present in early infection by CTL escape mutant (EM) strains during later infection. Using a strain-specific real time PCR
assay, we quantified the relative amounts of WT and EM strains in plasma SIV RNA and cellular SIV DNA. Thus we can track
the formation and turnover of SIV DNA in sorted resting CD4+ T cells. We studied serial plasma and PBMC samples from 20
SIV-infected Mane-A*10 positive pigtail macaques that have a signature Gag CTL escape mutation. In animals with low viral
load, WT virus laid down early in infection is extremely stable, and the decay of this WT species is very slow, consistent with
findings in subjects on anti-retroviral medications. However, during active, high level infection, most SIV DNA in resting cells
was turning over rapidly, suggesting a large pool of short-lived DNA produced by recent infection events. Our results
suggest that, in order to reduce the formation of a stable population of SIV DNA, it will be important either to intervene very
early or intervene during active replication.
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Introduction
Treatment of HIV-1 infected individuals with highly active
antiretroviral therapy (HAART) can suppress plasma viral RNA
levels below the threshold of detection by standard diagnostic assays.
However after cessation of even long-term HAART, virus replication
is quickly re-established [1–4]. A barrier to viral eradication is the
presence of viral DNA stably integrated into the chromosomes of
resting CD4+ T cells and other long-lived cell populations, since the
decay of this viral compartment is very slow [5–17].
Several studies suggest that persisting integrated viruses are laid
down early in infection [18–20]. An indication for this is that HIV
strains cultured from resting CD4+ T cells are genetically distinct to
concurrent plasma virus [20]. However, it is generally difficult to
study the precise kinetics of establishment and turnover of the latent
reservoirinmosthumancohortsastheinfectingisolateisusuallynot
known and serial samples available during asymptomatic early
infection (1–2 weeks post transmission) are difficult to acquire.
Studying macaques experimentally infected with SIV overcomes
these barriers. Recent studies show the utility of SIV-infected
macaque models for studying long-term integrated viruses [21–23].
During HIV and SIV infection one typically sees immune
escape at defined cytotoxic T cell lymphocyte (CTL) epitopes.
CTL escape mutations (EM) are frequently generated early after
the acute infection stage and typically follow predictable patterns
of outgrowing wild type (WT) virus. We hypothesised that
evidence for the early formation and turnover of SIV DNA may
be found by comparing the dynamics of immune escape in cellular
viral DNA populations to the dynamics in replicating plasma virus.
If replicating WT virus (as indicated by plasma RNA) is only
present during acute infection, and is completely replaced in
plasma by replicating EM virus during chronic infection, the latent
reservoir will be primarily WT if laid down during acute infection,
but predominantly EM if laid down (or rapidly turned-over)
during chronic infection. In other words, if WT viral DNA is
detected in resting CD4+ T cells during chronic infection and
remains at similar levels when measured later, this supports low
rates of turnover of viral DNA populations during active infection.
We previously developed sensitive real-time PCR assays to
quantify EM and WT viruses at a Mane-A*10-restricted SIV Gag
CTL epitope (termed KP9) in replicating plasma RNA [24],
essentially providing a ‘‘viral load’’ of both WT and EM
quasispecies. For this study, we also developed PCR assays to
assess WT and EM populations in cellular SIV DNA in FACS-
sorted resting CD4+ T cells. After obtaining serial plasma and
PBMC samples from Mane-A*10 positive SIV-infected pigtail
macaques, we used the observed evolution of WT and EM
replicating plasma SIV RNA viruses to model the turnover rate
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DNA sequences. These analyses suggest that during periods of
active high-level infection, the majority of SIV DNA in resting
CD4+ T cells is turning over very rapidly. However, at lower levels
of infection a substantial proportion of SIV DNA in resting CD4+
T cells is laid down early (when virus is still WT at the CTL
epitope) and this WT reservoir persists at stable high levels during
chronic infection.
Results
Rapid immune escape in plasma virus
We first studied 12 Mane-A*10+ animals in a SIV vaccine trial
using an influenza virus vector, as this large study provided an
extensive bank of plasma and PBMC samples (Table 1). We
characterized the frequency of CTL escape mutant and wild-type
variants in SIV plasma RNA (Figure 1A). The evolution of EM
and WT viruses in plasma was derived by a previously described
SIV Gag KP9 qRT-PCR that specifically discriminates the
K165R EM virus [24]. After infection with the SIVmac251
challenge stock, peak SIV viremia with predominating WT virus
was observed ,2 weeks post infection in all animals. K165R CTL
immune escape predictably occurred [24,25] and EM virus
predominated in chronic infection, being selected in preference
to WT virus in the majority of animals. Several animals had
plasma viremia trajectories in which there was minimal or no
detectable EM virus in plasma during acute infection, and
complete or near complete replacement of WT virus with EM
virus in plasma during chronic infection.
Rapid turnover of SIV DNA within resting CD4 T cells
during active infection
To assess SIV DNA within resting CD4 T cells, we sorted cells
based on their being positive for CD3 and CD4 and negative for
HLA-DR and CD69/CD25 (Figure 1B), and then performed a
nested PCR with the second round being specific for either WT or
the K165R CTL EM virus (Figure 1C). All animals were infected
with SIVmac251 that is WT at this CTL epitope. The PCR provides
relative levels of EM and WT SIV DNA in resting CD4 T cells.
We performed assays on FACS-sorted resting CD4 T cells
obtained from PBMC samples collected over the course of
infection, and compared the ratio of WT and EM virus in plasma
with that in SIV DNA in resting cells (Figure 1D).
These two ratios of WT/EM are the basis of the ‘‘escape clock’’
that we use to estimate the SIV DNA turnover rate in resting cells.
The method is outlined in the in Figure 2. Briefly, if SIV DNA
turns over quickly (or has a short half-life), then we expect the
fraction of WT virus in SIV DNA to closely track the ratio seen in
plasma virus, since most of SIV DNA would have been recently
formed from plasma virus. If, on the other hand, SIV DNA is
extremely stable (or persists indefinitely), then we expect the
fraction of WT in SIV DNA to reflect the accumulation of all
latently infected cells over the whole previous course of infection.
The archived viral DNA of each strain should then be
proportional to the ‘area under the curve’ (AUC) of each virus
over time. For any SIV DNA ratio in between these extremes, we
could estimate the optimal half-life of SIV DNA that best fits the
data using the model described in the Methods section.
In the majority of these animals with active replication (which
had high viral loads) we observed that CTL escape in the plasma
SIV RNA was closely followed by CTL escape in the SIV DNA
from FACS-sorted resting CD4 T cells (first 8 animals in Figure 3).
The estimated half-life of SIV DNA was therefore extremely short
– of the order of a few days.
To confirm these results we also assessed reversion of the
K165R KP9 CTL escape mutation in a Mane-A*10 negative
animal infected with the SHIVmn229 challenge stock. This
challenge stock had previously been passaged in a Mane-A*10+
animal and was composed largely of the K165R escape mutation
[26]. In the absence of CTL pressure, we observe plasma SIV
RNA rapidly reverting back to wild type, as previously reported
[26]. Thus, this provides an ‘escape clock’ where EM instead of
WT virus is temporarily expressed, and thus provides an excellent
control for our measurements of WT:EM ratio. Consistent with
our findings with WT SIVmac251 infection, we found that the
cellular SIV DNA in resting CD4 T cells also reverted back to wild
type very rapidly in this animal with high levels of viral replication
(Figure 4).
Slow turnover of SIV DNA in animals with low viral loads
The rapid turnover of cellular SIV DNA in resting CD4 T cells
that we observed during high level SIV infection above was
surprising, given the accepted stability of the latent reservoir in
subjects with very low levels of replication on HAART. To
investigate the effects of plasma viral turnover on the persistence of
SIV DNA, we repeated the study on a cohort of 8 Mane-A*10+
animals from a peptide immunotherapy trial. These animals had
undergone ART at week 3, followed by immunotherapy and
cessation of ART (week 10), leading to long-term low levels of viral
replication in many animals. In these animals, escape was usually
observed in the plasma following therapy interruption, leading to
the rapid appearance and dominance of EM virus in chronic
infection. Thus we were able to study SIV DNA dynamics in
resting CD4+ T cells in chronic infection at a time of low viral
loads in the absence of therapy. The results of fitting the half-life of
WT DNA in animals from both trials are shown in Figure 3, in the
order of increasing estimated half-life.
Analysis of the proportion of WT SIV DNA in resting cells from
these animals produced a very different picture from that seen in
the first cohort. In several animals, the SIV DNA in resting cells
remained close to 100% WT, despite EM virus dominating the
plasma for prolonged periods. When we estimated the half-life of
SIV-DNA in these resting cells using the ‘escape clock’ approach,
Author Summary
New treatments for HIV have proved very successful at
controlling viral replication and preventing the onset of
AIDS. However, these treatments must be continued for
life, because if they are stopped the virus rapidly
‘rebounds’ to its original levels. The reason for this
rebound is the existence of a population of viruses that
lie dormant inside cells during treatment, and reactivate as
soon as treatment is stopped. This ‘latent virus’ is
extremely long-lived under drug therapy conditions, and
therefore presents a major barrier to viral eradication.
However, very little is known about the survival and
reactivation of latently infected cells during ongoing
infection, because virus is being formed and destroyed
all the time. We have developed a novel ‘escape clock’
approach to measure how long viral DNA lasts in monkeys.
We find that, in the setting of low viral load, the lifespan of
infected cells is very long, whereas during active infection
there is a surprisingly high turnover of viral DNA within
resting CD4 T cells. We believe this is due to high level of
immune activation when there is a high level of replicating
virus. This result may have important implications for the
optimal timing of drug treatment.
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SIV-DNA in resting cells was .20 years. In several other animals,
although some turnover could be measured, the half-lives were
extremely long.
We then investigated whether viral load was a correlate of the
rate of SIV DNA turnover in sorted resting CD4+ T cells. We
observed a significant correlation between viral load and estimated
SIV DNA half-life (Figure 5), suggesting that the high levels of
infection and CD4+ T cell activation may play a role in
determining SIV DNA turnover.
Discussion
Current HAART regimes suppress plasma HIV RNA to very
low levels, but cessation of HAART results in a brisk rebound of
plasma virus [1–4]. Cellular compartments containing viral DNA
provide a stable long-term reservoir for the virus [5–17]. However,
the dynamics of establishment and turnover of this reservoir are
not well understood. In particular, the majority of studies of HIV
latency have focused on HIV DNA turnover under therapy, when
viral replication and CD4+ T cell activation and turnover are
greatly suppressed. But is HIV DNA persistence the same during
active infection?
Our approach using a qRT-PCR to track the evolution of CTL
escape mutants allowed us to compare EM and WT virus in
plasma RNA and cellular DNA in a cohort of Mane-A*10 positive
SIV-infected pigtail macaques. By analysing SIV DNA in purified
resting CD4 T cells and comparing with plasma virus, we show
that WT SIV DNA can persist in some animals for many months,
even where there is an absence of WT viral RNA in replicating
plasma virus. Thus, the WT SIV DNA species that are laid down
early during infection can persist into late infection, and turnover
of this viral compartment is very slow. Importantly however, this
long half-life of WT DNA was only seen in animals with low viral
loads. Animals with a high viral load showed a very rapid turnover
of WT SIV DNA in resting CD4+ T cells. Indeed, we observed a
highly significant correlation between the average viral load in
chronic infection and the estimated half-life of SIV DNA. This
correlation suggests that viral load is an important factor driving
SIV DNA turnover in resting CD4 T cells during active infection.
Our observation of the long half-life of SIV DNA associated
with low levels of plasma virus is consistent with the previous
studies of HIV DNA persistence under drug therapy, where viral
loads are even lower than those observed here [14]. What is less
clear from our study is why we see such a rapid SIV DNA
turnover in resting cells during active infection. A number of
mechanisms are possible. Firstly, it seems possible that CD4+ T
cells simply don’t get a chance to stay in the resting state long
enough to maintain a stable integrated pool, since SIV DNA is
continuously driven to productive infection because of host cell
Table 1. Macaques studied.
Monkey ID Challenge Mode Challenge Dose Vaccination ART treatment Reference
1335 intrarectal 10
4 TCID50 Flu-KP9* none Reece et al Plos One
2010
2374 intrarectal 10
4 TCID50 Flu-KP9
25377 intravaginal 2610
4 TCID50 Flu-SIV none NA
C0933 intravaginal 2610
4 TCID50 Flu-SIV
B0547 intravaginal 2610
4 TCID50 Flu-SIV
B0517 intravaginal 2610
4 TCID50 Flu-SIV
B0526 intravaginal 2610
4 TCID50 Flu-SIV
19341 intravaginal 2610
4 TCID50 none
19351 intravaginal 2610
4 TCID50 none
B0508 intravaginal 2610
4 TCID50 none
C3751 intrarectal 10
4 TCID50 none
C5873 intrarectal 10
4 TCID50 none
1.3731 intravenous 40 TCID50 15mer peptides spanning
all SIV Proteins
Tenofovir (TDF) and
Emtricitabine (FTC), week
3 to week 10 after SIV infection
De Rose et al. Plos Path
2008
8014 intravenous 40 TCID50 none
8020 intravenous 40 TCID50 Gag 15mer peptides
8244 intravenous 40 TCID50 Gag 15mer peptides
9021 intravenous 40 TCID50 15mer peptides
spanning all SIV Proteins
9175 intravenous 40 TCID50 15mer peptides
spanning all SIV Proteins
9183 intravenous 40 TCID50 none
5424 intravenous 40 TCID50 none none Smith et al. J Virol.
2004
1.7105 intrarectal 5610
4 TCID50 DNA/Fowlpox virus none Dale et al. J Virol. 2004
*Flu-KP9 is recombinant Influenza viruses expressing SIV Gag KP9 CTL epitope; Flu-SIV is recombinant influenza viruses expressing SIV Gag KP9 CTL epitope and 2 SIV
Tat CLT epitopes (KSA10 and KVA10).
doi:10.1371/journal.ppat.1002615.t001
‘‘Escape Clock’’ for Turnover of SIV DNA
PLoS Pathogens | www.plospathogens.org 3 April 2012 | Volume 8 | Issue 4 | e1002615activation. The half-life that we are estimating here is then half-life
spent in the ‘‘resting’’ pool, i.e. the time during which infected cells
express CD3 and CD4 and are negative for HLA-DR, CD69 and
CD25. When they activate, they are no longer sorted as resting,
and are lost from the pool in the same way as if they died. One
limitation to our conclusions about the latent infection is that they
apply only to CD69
2CD25
2HLA-DR
2 infected CD4+ T cells in
blood, which may not truly represent the latent pool, but may be a
heterogeneous population containing truly latently infected cells as
a small subset. Thus, although the observed average turnover of
HIV DNA in these resting CD4+ T cells is sometimes extremely
fast, we cannot exclude that there might be minor populations of
cells harbouring much longer-lived DNA, or that indeed long-lived
DNA might not be harboured at some other anatomical site.
Although we also found very few effector memory or dividing cells
within the sorted resting CD4 T cell population, future studies
could sort even more highly refined resting CD4 T cell populations
or investigate other anatomical sites to evaluate this further.
A second possibility is that the observed SIV DNA represents a
mix of long-lived, integrated SIV DNA, and of short lived reverse
transcription products that represent dead-ends for the virus. At
low viral loads, the level of short-lived reverse transcription
products is very low, as there is little virus present in plasma to
produce new infections. Thus, the SIV DNA observed comes
predominantly from the long-lived integrated pool, and we
observe the slow SIV DNA turnover characteristic of this
compartment. However, in animals with a high viral load, we
may see a high level of recent infection and of short-lived reverse-
transcripts. If viral loads are high enough, this pool of recent
reverse transcripts is the dominant population we see, overwhelm-
ing the long-lived WT DNA, and leading to an apparent close
tracking of the viral DNA in resting cells with the plasma DNA.
This mechanism also predicts that the long-lived WT DNA pool
always persists at the same level, but is numerically overwhelmed
by the large number of copies of short-lived EM DNA when
plasma viral load is high.
In our model we did not consider a possibility that the half-life
of infected resting cells depends on viral strain, because we
assumed that they would not express viral epitopes and would not
be recognized while resting. In addition, the fraction of WT DNA
in resting cells is in most cases higher than in plasma, which is not
supportive of preferential killing of resting cells with WT DNA.
However, it is in principle possible that WT-infected resting cells
are preferentially killed during periods of fast turnover, when the
WT fraction is very low and approaches that in plasma. We note
though that if preferential killing of WT infected resting CD4+ T
cells were driving the rapid turnover of latency, we might expect
that the turnover would be correlated with CTL number.
Specifically, if this were the mechanism driving the turnover, we
would expect that in animals with good CTL control (low viral
loads) we should see faster turnover of HIV-DNA. However, we
observed the opposite relationship. Moreover, when we analysed
the correlation between the number of tetramer positive cells and
HIV-DNA turnover, we found that both in early (before the
appearance of EM in plasma) and in chronic infection the average
number of tetramer positive cells was positively correlated with the
estimated half-life of resting infected cells. This is in agreement
with our interpretation that better immune control leads to less
reactivation of latently infected cells.
Our analyses are in agreement with early studies in humans
suggesting that latent reservoirs in resting CD4+ T cells are laid
down earlier in infection and are extremely long-lived [20,27].
There are a number of possible mechanisms by which long-lived
SIV/HIV DNA may persist in cells (illustrated in Figure 6). Firstly,
the individual cells bearing HIV DNA may be extremely long-
lived. Secondly, these cells may turn over through homeostatic
replication, with a balance of cell replication and death leading to
a stable number of HIV DNA copies. Finally, it has been suggested
that HIV persistence may be maintained by low levels of viral
reactivation, replication, and reinfection of new cells, leading to a
stable level of HIV DNA copies. This latter mechanism seems
unlikely at low plasma viral loads given our results. That is, if WT
DNA persistence involved reactivation, viral production into the
plasma, and reinfection of new cells, then we should be able to
estimate the proportion of new infections due to WT virus, by the
ratio of WT: EM virus in the plasma. However, since in most cases
we don’t observe any WT virus in the plasma in chronic infection,
it could at best make only a very trivial contribution to any
reinfection, and could not maintain WT DNA levels at or above
the AUC levels via this mechanism.
There are limitations to our data that suggest further studies.
Discriminating integrated from non-integrated forms of SIV DNA
was not feasible in the small numbers of sorted resting CD4 T cells
without further optimising the assay. Several assays have been
Figure 1. Measuring WT and EM virus in plasma and resting
CD4+ T cells. (A) The levels of WT and EM virus in plasma were
estimated using a variant-specific real-time PCR assay, shown here for
animal 1335. In order to estimate the proportion of WT virus in resting
CD4+ T cells, cells were first sorted (B), and then DNA extracted and the
levels of WT and EM virus measured using the variant-specific PCR (C).
Combining this data, we can plot the fraction of WT virus in the plasma
(closed squares) and resting CD4+ T cells (open squares) over time (D).
doi:10.1371/journal.ppat.1002615.g001
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HIV/SIV such as 1 LTR and 2-LTR circular forms, and these
could be used in the future to determine the level of contaminating
non-integrated SIV [28–31]. No widely accepted method exists to
measure the ‘‘true’’ latent reservoir and our studies of resting CD4
T cells are only an approximation of this as yet undefined cell
population. PCR-based assays have the disadvantage in that much
of the cellular HIV-1 DNA may be from replication-deficient
virus, although for viruses to contribute to the latent reservoir they
must be replication-competent [20,32]. However, our analyses
focus only on a single nucleotide change in the KP9 CTL epitope.
This change (alone) is replication competent and it seems unlikely
that additional lethal mutations would accumulate more com-
monly in either WT or the K165R EM species.
Our results provide a method for direct quantification of HIV
DNA turnover during active infection, and show for the first time
that SIV DNA turnover in resting CD4+ T cells is strongly
correlated with viral load during chronic infection. The rapid
turnover of SIV DNA in animals with high viral load suggests the
resting pool of CD4+ T cells and the pool of SIV DNA may be
much more dynamic than previously thought during active
infection. However, the persistence of WT SIV DNA laid down
in early infection in animals with low chronic viral loads indicates
the importance of the earliest stages of infection in establishing the
latent pool of HIV DNA. Taken together, our study highlights the
importance of early viral control in preventing the establishment of
persistent HIV infection.
Materials and Methods
Ethics statement
Experiments on pigtail macaques (Macaca nemestrina) were
approved by CSIRO livestock industries Animal Ethics Commit-
tees (approval number 1315) and cared for in accordance with
Australian National Health and Medical Research Council
guidelines.
Animals
We studied serial PBMC and plasma samples from 20 pigtail
macaques involved in several SIV infection studies [33,34]. Five
Figure 2. Estimating the half-life of SIV-DNA in resting cells using the ‘escape clock.’ The fitting of the experimental data for animal 1335 is
shown to illustrate the modelling approach. Panel A illustrates the approach using a single timepoint late in infection. In the top figure in panel A, the
levels of WT (red) and total (WT + EM, blue) virus are plotted over time (on a linear scale). The shaded rectangle indicates the current fraction of WT
virus on day 105 post-infection in plasma (pink for WT and light blue for EM). If viral DNA turned over fast (with half-life of half a day or less), both WT
and EM would follow the ratio in plasma and we would expect nearly 100% EM SIV DNA in resting CD4+ T cells on day 105. The bottom half of panel
A represents the case when viral DNA does not decay (has infinite half-life). In this case, viral DNA accumulates all the time since inoculation, and the
amount of each virus type follows the area under the curve (AUC) of WT (#Wdt) and EM (#Edt) viral load. The scale of viral DNA is linear in arbitrary
units. In this case we would expect a much higher WT fraction in viral DNA in resting cells on day 105 (rectangle). The box in the middle on the right
of panel A shows the experimentally measured fraction of WT DNA in resting cells, which is between the two extremes. This implies that the half-life
of viral DNA lies between 0.5 days and infinite time. Panel B illustrates the fitting of the optimal half-life of SIV-DNA using the longitudinal data for
animal 1335. The green circles are the experimental values of WT virus fraction in plasma over time; the blue circles are the fraction of WT virus
estimated from the AUC of viral load. The red squares show the experimentally observed fraction of WT virus SIV DNA in resting CD4+ T cells. The
black line illustrates the fraction of WT virus expected from the model (Eq.2) with different values of SIV DNA half-life. The top left figure shows the
estimated DNA fraction for half-life of 0.5 days, which follows the experimental plasma fraction closely, but is considerably below the observed DNA
fraction. The top right figure shows the DNA fraction estimated from infinite lifetime (area under the curve), which is higher than the observed
fraction in the later stage of infection. The larger figure at the bottom shows the estimate using the best-fit lifetime of 21.1 days, which closely follows
the observed variation of WT DNA.
doi:10.1371/journal.ppat.1002615.g002
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SIVmac251 (wild type at KP9) [35]. Two macaques received
influenza viruses expressing KP9 and were infected with SIVmac251
[34]. Five macaques received influenza viruses expressing KP9,
KSA10 and KVA10. Eight Mane-A*10 positive pigtail macaques
were enrolled in a therapeutic peptide-based vaccine trial [33].
The outline of the therapeutic study was as follows: pigtail
macaques were infected intravenously with SIVmac251 at week 0
Figure 3. Estimating the half-life of SIV DNA in resting CD4+ T cells. The proportion of WT virus in plasma (green circles), the fraction of WT
virus estimated from the area under the curve (AUC) of viral load (blue circles) and the experimentally observed fraction of WT virus SIV DNA in
resting CD4+ T cells (red squares) are shown for each animal in the top part of each panel. The black line illustrates the best-fit SIV DNA half-life to the
observed fraction of WT virus in resting CD4+ T cells for each animal. Animals are arranged in order of increasing half-life of SIV DNA. The bottom part
of each panel (black triangles) represents total plasma viral load. Viral loads are all on the same log10 scale, from 10–10
9. The bottom right two panels
(B0517 and B0547) illustrate two animals in which EM appeared only transiently in plasma. In this case, the fraction WT virus is nearly 100% in both
plasma and AUC estimates at the time points where DNA was measured, so the ‘escape clock’ fits equally well with a half-life of 1 day or 100,000 days.
doi:10.1371/journal.ppat.1002615.g003
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post infection and then withdrawn. Either no treatment (controls)
or OPAL treatment (overlapping 15mer Gag peptides only or
peptides from all 9 SIV proteins) was given at weeks 4, 6, 8 and 10
after infection. PBMC and plasma samples were collected at
regular time points on all animals. The animals and their
treatment are summarized in Table 1.
Analyses of WT and EM virus in plasma RNA
To quantify virus levels of WT or EM quasispecies at the KP9
epitope we employed a discriminatory real-time PCR assay as
described [24,36]. Briefly, the assay uses a forward primer specific
for either wild-type sequence or specific for the nucleotide
mutation encoding the dominant K165R KP9 escape mutant.
At each timepoint after infection 10 ml of plasma RNA was
reverse-transcribed and then amplified by qRT-PCR using either
WT or EM forward primers. A common reverse primer and
FAM-labelled DNA probe were also added for quantification
against the appropriate SIV Gag epitope RNA standards using an
Eppendorf Realplex
4 cycler. Analysis was performed using
Eppendorf Realplex software. Baselines were set 2 cycles earlier
than real reported fluorescence and threshold value was
determined by setting threshold bar within the linear data phase.
Samples amplifying after 40 cycles were regarded as negative, and
corresponded to ,1.5-Log10 SIV RNA copies/ml of plasma.
Plasma viral cDNA was also subjected to Sanger-based sequencing
as previously described [37] to confirm the EM quasispecies
contained the K165R mutation detected in the qRT-PCR assay.
Sorting resting CD4 T cells
We studied HLA-DR-CD692CD252 CD4+CD3+ T lympho-
cytes as resting CD4 T cells as these cells are commonly studied as
a model for resting CD4 T cells [32,38–41]. Frozen PBMC
(approximately 5610
6) were thawed at 37uC in RF10, centrifuged
at 300 g and resuspended in 500 ul of PBS containing 2 mM
EDTA. 0.5 ml live/dead (Near Infra Red –IR (APC-Cy7) viability
stain/tube was added and tubes were incubated for 60 minutes on
ice in the dark. Cells were washed for 5 min at 500 g, the
supernatant removed and surface stained with an antibody
cocktail of CD69-APC (clone L78), CD3-PE (clone SP34-2),
CD4-FITC (clone L200), CD25-APC (clone BC96) and HLA-DR-
PerCP Cy5.5 (clone L243) on ice in the dark for 60 minutes to
avoid CD4 T cell activation. PBMC were washed in PBS
containing 0.5% BSA and 2 mM EDTA, fixed in 0.1%
formaldehyde and passed through filtered facs tube prior to being
sorted on the FACSAria. Live resting CD4+ T cells were positive
for CD3 and CD4 and negative for HLA-DR and CD69/CD25.
To validate whether HLA-DR-CD692CD252 CD4+CD3+ T
lymphocytes studied were truly resting using other markers we also
studied CD28 and CD29 memory markers and the cell turnover
marker Ki67 in a subset of the studied animals. The activated cells
were highly enriched for CD28295+ effector memory cells. A
mean of only 0.91% of the resting cells were of the effector
memory phenotype (p,0.001). The activated cells were also
highly enriched for Ki67 staining (p=0.0028). A mean of only
1.64% of the resting cells were Ki67+.
Nested real-time PCR to assess WT and EM SIV DNA
DNA from sorted cells was extracted using the Qiagen mini DNA.
A nested KP9-specific qRT-PCR was performed that consisted of a
first round Gag specific PCR followed by a second round discrimi-
natory KP9 qRT-PCR. The first round PCR utilized 400 nM of the
Gag forward primer (59- CAAGTAGACCAACAGCACCATC-
TAGCGGCAG-39) and reverse primer (59- CTTGTTGTGGAGC-
TGGTTGTGGGTGCTGCAAGTC). Amplification was performed
using 2 U Expand High Fidelity polymerase, 200 nM dNTPs and
250 mM MgCl2 per reaction. Amplification consisted of 94uCf o r
2 minutes followed by 22 cycles of 94uC for 15 seconds, 68uCf o r
30 seconds and 72uC for 45 seconds, with a final extension of 72uC
Figure 4. Reversion in animal 1.7105. Mane-A*10 negative animal
1.7105 was challenged with SHIVmn229, which is a viral stock containing
10% WT and 90% K165R escape mutation at the Gag KP9 epitope. In
the absence of KP9-specific immune response, virus quickly reverts to
WT. During reversion, the fraction of WT in resting CD4+ T cells closely
follows the fraction in plasma, similarly to the escape pattern in Mane-
A*10 positive animals with high chronic viral loads challenged with WT
SIV251.
doi:10.1371/journal.ppat.1002615.g004
Figure 5. SIV DNA half-life decreases with increasing chronic
plasma viral load. The chronic plasma viral load (estimated as the
geometric mean viral load from day 100 post-infection) is significantly
correlated with the estimated half-life of SIV DNA for each animal
(Spearman correlation, r=20.8358, p,0.0001). The error bars represent
confidence intervals (C. I); ‘‘*’’ marks the C. I. limit ,0.5 days and ‘‘+’’
marks the C. I. limit .10
5 days.
doi:10.1371/journal.ppat.1002615.g005
‘‘Escape Clock’’ for Turnover of SIV DNA
PLoS Pathogens | www.plospathogens.org 7 April 2012 | Volume 8 | Issue 4 | e1002615for 7 minutes. The second round dKP9 qRT-PCR has previously
been described for the analysis of WT and EM virus in plasma RNA,
was performed [24,36]. The second round product was serially diluted
1/100 to 1/2000 to ensure that the second round qRT-PCR did not
contain saturating amounts of DNA. Sanger based sequencing
confirmed the ratios of WT:EM virus observed in the real-time
PCR reaction (not shown).
Modeling SIV DNA turnover
We start from a simple model describing WT and EM infection
in resting CD4+ T cells:
dRW
dt
~mIW{
ln2
tR
RW
dRE
dt
~mIE{
ln2
tR
RE
ð1Þ
In this model, cells infected with WT and EM (IW and IE
respectively) are becoming resting (RW and RE for resting cells
infected with WT or EM respectively) at a fixed rate m and have a
half-life of tR. Half-life can describe the loss of resting cells either to
death or to activation. We do not have access to IW and IE from
experiment, but we assume that free virus is turning over much
faster than productively infected cells [42], so that plasma virus to
a good approximation reflects the corresponding productively
infected cell level. This proportionality holds irrespective of the
cause of viral load variation – be it because of the variation in
target cell numbers, immune response or drug therapy. It allows us
to replace mIW and mIE in Eq.1 with fW and fE, where W and E
are the plasma WT and EM viral loads, and f is a constant
different from m.
We then use this model to estimate the half-life of viral DNA in
resting infected cells using the measured WT and EM viral loads
and the fraction of WT DNA in resting cells bW=RW/(RW+RE).
For this purpose we rewrite the system Eq.1 (with W and E
replacing IW and IE) in terms of the WT fraction bW and a variable
L representing total number of infected resting cells scaled by
constant f, L=(RW+RE)/f:
dL
dt
~WzE{
ln2
tR
L
dbW
dt
~
W
L
{
WzE
L
bW
ð2Þ
The system Eq.2 has only one fitting parameter, the half-life of
viral DNA tR. We find the best fit of tR for each animal by solving
Eq.2 with initial conditions L(t=0)=1 and bW(t=0)=1 (because
inoculating SIVmac251 is 100% WT) and choosing a value of
d=ln2/tR between 0 and 2 such that it minimizes the deviations
from measured points of WT DNA fraction, using measured
values of WT and EM viral load with exponential interpolation
between time points for the variables W and E. Because the fitted
values of the WT fraction bW must lie between 0 and 1, the best-fit
value of d has to minimize the expression [43]:
S(d)~
X N
i~1
arcsin
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
pred
W (ti)
q   
{arcsin
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
expt
W (ti)
q        2
ð3Þ
where ti are the time points when the measurements were taken,
bW
expt are the measured values of the WT fraction at this point, and
bW
pred are the values predicted by the model. The arcsin-square
root transformation of the deviations was used to normalize the
error distribution.
Given the initial conditions, the solution L(t), bW(t) of the system
Eq.2 for each value of tR is unique. Therefore it is sufficient to
have one experimental WT fraction different from 1 or 0 to
completely define the trajectory of WT fraction in time. We have
such points for all animals. Even when a fraction looks like 1 or 0,
it often deviates a little from these numbers. The largest possible
value of tR that could be obtained from our model is infinity
Figure 6. SIV DNA persistence does not require reinfection.
Several mechanisms have been postulated for the persistence of HIV
DNA under prolonged therapy. (A) Infected cells harbouring HIV DNA
may be long-lived, or (B) may undergo homeostatic replication, in
which the daughter cell carries the HIV DNA. Panel C illustrates one
possible mechanism of viral persistence under therapy, where latent
cells become reactivated, shed virus and die, leading to the infection of
a new generation of cells. However, during active infection (D),
activation of latent WT infected cells (red) leads to production of small
amounts of WT virus (red) that is effectively diluted by the abundance
of EM virus in plasma (blue). Thus, reinfection is predominantly with EM
virus, and the WT is effectively removed by activation and replication.
The long-term persistence of WT SIV-DNA despite EM dominance in
plasma, at levels at or above the AUC estimate (in animals 9021, 9175,
5424, 8020) make reinfection a very unlikely contributor to SIV DNA
persistence.
doi:10.1371/journal.ppat.1002615.g006
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5 because d=10
25 is the lowest
parameter value used that was greater than zero), and the lowest
possible value is 0.35 days (if this is the best fit, we report it as ,0.5
days).
The confidence intervals for each animal in Figure 5 are
obtained by bootstrapping, using the errors transformed by arcsin-
square root. The initial point bW(0)=1 was not used in
bootstrapping. Because the total number of measurements for
each animal was small, we used the whole set of error
permutations to determine the bounds of the confidence intervals.
Our model assumes that the constant f is the same for cells
infected with WT and EM. However, this constant may be higher
or lower in one of the strains, depending on its propensity m to
generate latently infected cells, fitness cost of mutation and type of
immune response. We have therefore repeated the process by
simultaneously fitting the ratio fE/fW and tR and found that this
did not change the range of observed half-lives or the correlation
of half-lives with chronic viral load. The details of this analysis are
shown in the Text S1 in the online Supplementary material.
It should be noted that RW and RE, which we regarded as
infected resting cells in Eq.1 and Eq.2, can also be interpreted as
the WT or EM DNA content in resting cells (just as IW and IE can
represent viral DNA in productively infected cells), In this case, the
half-life of tR describes the loss of viral DNA due to cell death,
degradation or resting cells becoming activated.
Supporting Information
Text S1 Estimate of half-life of resting infected CD4+ T cells
when fW?fE. We derive the extended model where the rates of
infected cells becoming latent differ between cells infected with
WT and EM and we show that the negative correlation between
half-life of latently infected cells and chronic viral load is preserved
in the 2-parameter fit.
(PDF)
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